INVO Fertility (IVF) EGM 2026 summary

Opening remarks and agenda

• Meeting called to order virtually at 12:00 P.M. ET on January 22, 2026, with technical support available for participants.

• CEO, CFO, Corporate Secretary, legal counsel, and Inspector of Election present; CEO acts as Chairperson.

• Formal steps for meeting notice and record date confirmed; notice mailed to all eligible stockholders.

Specific resolutions to be voted on

• Ratification of WithumSmith+Brown, PC as independent auditor for fiscal year ending December 31, 2025.

• Approval of issuance of up to 4,733,728 shares upon warrant exercise from a private placement.

• Amendment to increase authorized common stock from 6,250,000 to 250,000,000 shares.

• Amendment to 2019 Stock Incentive Plan to increase available shares to 1,000,000.

• Approval of adjournment to solicit additional proxies if needed.

Corporate governance

• Quorum established with 944,054 shares (39.55% of outstanding) represented, exceeding the required one-third.

• Inspector of Election certified and oath filed with meeting minutes.

• Stockholder list available for inspection during the meeting.